Search

everythinglearnresearchcommunity

for

Search:↓

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Gray hair can potentially be reversed, leading to new treatments.

Exosomes from special stem cells help treat ulcerative colitis by reducing inflammation and stress.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Nivolumab can cause hair loss as a rare side effect.

Fibroblasts are crucial for tissue repair and inflammation, and understanding them can help treat fibrotic diseases.

New therapies are being developed that target integrin pathways to treat various diseases.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

A man's gray hair got darker and thicker after using a psoriasis drug.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Using radiation to make mice's hair turn gray helps study and find ways to prevent or reverse hair graying.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Premature graying and hair changes can be treated with certain peptides and possibly targeting the endocannabinoid system.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

Certain proteins can either protect against or increase the risk of hypertrophic scars.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.